Robbins Umeda LLP Announces the Filing of a Class Action Suit Against AEterna Zentaris, Inc.
Robbins Umeda LLP Announces the Filing of a Class Action Suit Against AEterna Zentaris, Inc. Business Wire SAN DIEGO -- June 18, 2012 Shareholder rights firm Robbins Umeda LLP announces the filing of a federal securities class action by an investor in the U.S. District Court for the Southern District of New York, on behalf of purchasers of AEterna Zentaris, Inc. (NASDAQ: AEZS) ("AEterna" or the "Company") shares between February 3, 2010 and April 1, 2012 (the "Class Period"). The complaint alleges that AEterna and certain of its executive officers issued false or misleading statements concerning the Company’s business and financial prospects. Specifically, it is alleged that defendants misrepresented and/or failed to accurately disclose material information about the prospects of perifosine, its development-stage colon cancer drug. On April 2, 2012, shares of AEterna plummeted after the Company announced that phase 3 clinical trials showed that perifosine administered with capecitabine was no more effective than capecitabine administered with a placebo in patients with refractory advanced colorectal cancer. Following the emergence of these facts, shares of AEterna lost approximately 67% of their value. After closing at $2.14 per share on March 30, 2012, shares of AEterna common stock closed on April 2, 2012 at just $0.73 per share. If you purchased or otherwise acquired AEterna stock during the Class Period and wish to serve as lead plaintiff, you must act no later than August 14, 2012. To discuss your shareholder rights, please contact attorney Gregory E. Del Gaizo at 800-350-6003, via email at firstname.lastname@example.org, or via the shareholder information form. Robbins Umeda LLP is a nationally recognized leader in securities litigation and shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. For more information, please go to http://www.robbinsumeda.com. Press release link: http://www.robbinsumeda.com/shareholders-rights-blog/aeterna-zentaris-inc/ Attorney Advertising. Past results do not guarantee a similar outcome. Contact: Robbins Umeda LLP Gregory E. Del Gaizo email@example.com (619) 525-3990 or Toll Free (800) 350-6003 www.robbinsumeda.com